Analysis of Prophylactic Parameters and the Relative Cut-off Values for Predicting Stromal Herpes Simplex Keratitis Recurrence

Background: To assess the potential values of clinical characters, tear HSV-sIgA and tear HSV-DNA for prediction of stromal HSK recurrence.Methods: Tears and serum IgG/IgM/IgA from 187 stromal HSK patients were collected. All the 187 tear samples serum samples were tested by ELISA for sIgA/ IgG/IgM/IgA. 146 tear samples were also tested by PCR for tear HSV-DNA. Subsequent follow-up time for monitoring recurrence was performed on all the 187 patients for 2 to 55 months.Results: The positive rate of tear HSV-sIgA was 36.90% (69/187), while for tear HSV-DNA, the positive rate was 10.96% (16/146). Totally 29 of the 187 participants experienced recurrence (15.51%). Previous episodes, tear HSV-sIgA–positive and tear HSV-DNA-positive patients had significantly shorter relapse-free survival (P<0.01, P<0.01 and P=0.0123 respectively). Patients combined univariate and multivariate analysis together, only tear HSV-sIgA was the factor for predicting the risk of herpes keratitis recurrence (HR=2.768, 95% CI =1.148-6.674, p= 0.023). By using Youden index, the concentration of tear HSV-sIgA >= 22.34 U/ul indicated a higher risks for relapse (sensitivity=79.31%, specificity=63.92%, Youden index=0.43).Conclusions: Though episode, tear HSV-sIgA and tear HSV-DNA all have high correlation with recurrent herpes keratitis, only tear HSV-sIgA is considered to be the most appropriated candidate for predicting the risk of recrudescent HSK. As tear HSV-sIgA >=22.34 U/ul, the risks for recurrence will be much higher. It is might be an appropriate cut-off value for predicting recurrence.

[1]  J. Yoo,et al.  Clinical Features of Herpes Simplex Keratitis in a Korean Tertiary Referral Center: Efficacy of Oral Antiviral and Ascorbic Acid on Recurrence , 2018, Korean journal of ophthalmology : KJO.

[2]  H. Agut,et al.  Recurrent herpetic keratitis despite antiviral prophylaxis: A virological and pharmacological study , 2017, Antiviral research.

[3]  Jianjiang Xu,et al.  The evaluation of diagnostic efficiency for stromal herpes simplex keratitis by the combination of tear HSV-sIgA and HSV-DNA , 2017, Graefe's Archive for Clinical and Experimental Ophthalmology.

[4]  J. C. Serna-Ojeda,et al.  Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents – comment , 2017, Clinical & experimental ophthalmology.

[5]  A. Huang,et al.  Herpes simplex keratitis: challenges in diagnosis and clinical management , 2017, Clinical ophthalmology.

[6]  Tong-xin Du,et al.  Real-time polymerase chain reaction for the diagnosis of necrotizing herpes stromal keratitis. , 2016, International journal of ophthalmology.

[7]  E. Takamura,et al.  A diagnostic method for herpes simplex keratitis by simultaneous measurement of viral DNA and virus-specific secretory IgA in tears: an evaluation , 2016, Japanese Journal of Ophthalmology.

[8]  Fei Huang,et al.  Tear HSV-Specific Secretory IgA as a Potential Indicator for Recurrent Stromal Herpes Simplex Keratitis: A Preliminary Study , 2013, Cornea.

[9]  Asim V. Farooq,et al.  Herpes simplex epithelial and stromal keratitis: an epidemiologic update. , 2012, Survey of ophthalmology.

[10]  N. Nayak,et al.  Evaluation of tear samples for Herpes Simplex Virus 1 (HSV) detection in suspected cases of viral keratitis using PCR assay and conventional laboratory diagnostic tools , 2010, British Journal of Ophthalmology.

[11]  E. Miserocchi,et al.  Comparison of the Efficacy of Valacyclovir vs Acyclovir for the Prevention of Recurrent Herpes Simplex Virus Eye Disease , 2005 .

[12]  E. Cohen,et al.  Long-term acyclovir use to prevent recurrent ocular herpes simplex virus infection. , 2003, Archives of ophthalmology.

[13]  C. Begley,et al.  Prevention of herpes simplex virus eye disease: a cost-effectiveness analysis. , 2003, Archives of ophthalmology.

[14]  Predictors of Recurrent Herpes Simplex Virus Keratitis , 2001 .

[15]  R. D. Stulting,et al.  Psychological stress and other potential triggers for recurrences of herpes simplex virus eye infections. Herpetic Eye Disease Study Group. , 2000, Archives of ophthalmology.

[16]  E. Donnenfeld Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. Herpetic Eye Disease Study Group. , 2000, Archives of ophthalmology.

[17]  P. Laibson,et al.  The impact of the herpetic eye disease studies on the management of herpes simplex virus ocular infections. , 1999, Current opinion in ophthalmology.

[18]  S. Thyagarajan,et al.  Tear secretory IgA: evaluation of usefulness as a diagnostic marker in herpetic keratitis. , 1999, Ocular immunology and inflammation.